Restoring Cancer Genomes: Functional Mutation Correction as a Platform for Precision Oncology

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Cancer genome sequencing reveals numerous somatic mutations, but identifying consequential and actionable alterations is challenging.
• Current oncology faces difficulties in determining the biological significance and therapeutic potential of identified cancer mutations.

Purpose of the Study:

• To explore the application of CRISPR-based genome editing for precise correction of oncogenic mutations.
• To discuss how programmable mutation correction advances cancer biology, personalized diagnostics, and precision gene therapies.
• To propose a conceptual shift towards actively testing the biological necessity of cancer mutations.

Main Methods:

• Utilizing CRISPR-based genome editing to precisely correct oncogenic mutations in their endogenous genomic context.
• Analyzing the functional consequences of mutation correction on transcriptional programs across diverse tumor types.
• Developing a scalable functional platform for stratifying cancer drivers and interrogating variants of uncertain significance.

Main Results:

• Repairing cancer hotspot mutations restored conserved, tumor-agnostic transcriptional programs.
• Demonstrated tumor-agnostic dependencies revealed by mutation correction.
• Established a framework for functional interrogation of cancer mutations.

Conclusions:

• Programmable mutation correction offers a powerful tool for advancing mechanistic cancer biology.
• This approach enhances personalized cancer diagnostics by stratifying drivers and variants of uncertain significance.
• Systematic reversal of cancer mutations represents a paradigm shift towards functional validation in precision oncology and gene therapy development.